GLP-1 · DOSAGE CALCULATOR
Pemvidutide Dosage Calculator
Pemvidutide is a weekly dual agonist dosed in milligrams. Enter your vial strength, water, and prescribed dose to see the syringe draw.
INPUT VALUES
Peptide vial size
5 mg
Total Pemvidutide in your vial
Bacteriostatic water
2 mL
Amount of BAC water added
Desired dose
1.2 mg
Trial doses were 1.2, 1.8, and 2.4 mg weekly without a titration phase.
RESULT · AUTO-CALCULATED
Draw to
units on a U-100 insulin syringe · 0.48 mL
- Concentration
- 2500 mcg/mL
- Volume per dose
- 0.48 mL
- mcg per unit
- 25 mcg
- Doses per vial
- 4
Educational only. Reconstitution math is provided to help you follow the instructions from your prescribing provider — it is not a dosing recommendation. Always use the dose your provider prescribed.
About Pemvidutide dosing
Pemvidutide is a balanced GLP-1/glucagon dual agonist from Altimmune, notable in trials for weight loss with a relatively high share of fat mass lost and for its effects on liver fat.
From a 5 mg vial in 2 mL (2.5 mg/mL), a 1.2 mg dose is 0.48 mL — 48 units — and the vial holds four doses. A 10 mg vial doubles that.
Pemvidutide is investigational and not prescribed at G1. A free consultation covers what is available for your goals.
What results has pemvidutide shown in clinical trials?
The MOMENTUM phase 2 trial reported average weight loss of roughly 10–16% at 48 weeks across the three doses, with lean-mass preservation better than typically seen with GLP-1 monotherapy.
How is pemvidutide dosed?
Once weekly by subcutaneous injection at 1.2, 1.8, or 2.4 mg. Trials did not use a titration phase, though a prescriber could still start low.
Is pemvidutide available at G1?
No — it remains in clinical development. Book a free consultation to discuss the peptides and medications G1 does prescribe.
NOT SURE WHERE TO START?
Talk to a licensed provider about your goals.
G1 does not currently carry Pemvidutide. A free telehealth consultation is the fastest way to find out what is right for you and what is available.